Organon & Co. Financial Ratios
OGN / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
24.9%
ROE ranks in the top 25% among Health Care companies
Profit Margin
3.0%
Net Income / Revenue
Asset Turnover
0.48
Revenue / Total Assets
Equity Multiplier
17.11
Total Assets / Equity
Composite: 24.9% (reported: 24.9%)
Profitability
Liquidity
Current Ratio
1.82
Quick Ratio
1.23
Solvency
Interest Coverage
1.39
Efficiency
Asset Turnover
0.48
Inventory Turnover
2.06
Days Sales Outstanding
78 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-4.0%
-3.4pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.